Sentence examples for maximal efficacy for from inspiring English sources

Therefore, maximal efficacy for MCMV infection was achieved with bupivacaine pre-medication i.m.

12 In vitro, the maximal efficacy for DPP-4 inhibition by linagliptin is comparable to that of the other DPP-4 inhibitors available today.

BRET data indicating proximity between the cell surface marker, Kras, and OX1, OX2 receptors and the OX1ctOX2 mutant revealed that a decreased level of the mutant OX1ctOX2 appears to be present at the cell surface, despite maintaining potency and maximal efficacy for orexin A-stimulated inositol phosphate production that was not different from that of either OX1 or OX2 receptors.

The use of specific tools for maximal efficacy of microbiome manipulation in relation to mouse development is summarized in Fig.  3.

Interestingly, the maximal efficacy of aleglitazar in recruiting cofactor peptides was 53 62 % that of RO4899100, except for SRC1_M1, which was recruited by aleglitazar to a similar extent (94 %) as it was by RO4899100 (Table  4).

At nanomolar concentrations, olodaterol significantly attenuated the LPS-induced release of TNF-α, CCL4, CCL2 and CXCL9 with a maximal efficacy of 45, 32, 43 and 54% and significantly reduced the mediator release from non-stimulated lung explants with a maximal efficacy of 46% for TNF-α, 42% for CCL4, 37% for CCL2 and 35% for CXCL9 (data not shown).

For example, a mixture of one full agonist with ten 10% partial agonists (with each agent dosed at its own EC50) will have a maximal efficacy of 2/11 (18%).

However, the selective β1-adrenoceptor antagonist CGP-20712A had no effect on the potency and maximal efficacy of olodaterol.

This lack of potency is critical for an aminoglycoside, because we found during standardization of the survival model that the dose required for maximal efficacy (768 mg/kg per day) was neurotoxic for the mice if given for more than 24 h, and a dose twice that (1536 mg/kg) was lethal.

The quantitative analysis and characterization of how the NPs' spectral peak wavelength and spectral broadness change upon interaction with cells will help guide NP design for maximal efficacy and safety in biological environments.

More recently, it has also provided an opportunity to modify the interaction and presentation of an antigen/adjuvant to the immune system to better stimulate the desired immune responses for maximal efficacy.